Management of Dyslipidemia in Primary and Secondary Prevention

Lipid screening is an important tool to assess an individual’s risk of developing atherosclerotic cardiovascular disease (ASCVD). The 2021 CCS Dyslipidemia Guidelines recommend screening of Total Cholesterol (TC), LDL-C, HDL-C, non-HDL-C, Triglycerides (TG) as well as once in a lifetime Lipoprotein(a) measurement and optional assessment of ApoB as part of a comprehensive risk assessment of ASCVD.

This webinar aims to improve health professionals’ knowledge of CCS Guideline-directed lipid screening and increase awareness of CCS Dyslipidemia tools and resources. Participants will engage in clinical scenarios, interactive discussion, and Q&A segments to facilitate the implementation of Guideline-directed lipid screening and the use of CCS tools and resources in their everyday practice.

Program Chairs: Dr. Anil Gupta and Dr. Grace Chua
Program Speakers: Dr. Iulia Iatan and Dr. Glen Pearson

Inscrivez-vous Opens in a new window